The Göttingen-based Max Planck Institutes (MPI) for Biophysical Chemistry and Experimental Medicine have merged as of January 1, 2022. This will establish a new MPI, the Max Planck Institute for Multidisciplinary Sciences. It will cover a much broader spectrum of research, thus promoting disciplinary diversity and collaboration. With a total of 16 departments and more than 25 research groups, the MPI for Multidisciplinary Sciences will be the largest institute in the Max Planck Society. MBExC speaker Patrick Cramer will serve as the Managing Director of the new MPI for the next two years.
Photo: © Johannes Pauly / Max Planck Institute for Multidisciplinary Sciences
